St. Jude Medical received European approval to market the company’s Genesis implantable pulse generator (IPG) for pain relief due to chronic angina. The spinal cord stimulator already has approval in the US and Europe for treatment of neuropathic pain of the trunk and limbs and pain from back surgeries that have failed.
From the product page:
Primary cell Implantable Pulse Generator (IPG) systems are best suited for patients with low to moderate energy requirements who do not desire or have the ability to maintain a rechargeable system.
The Genesis primary cell IPG is specifically designed to be easy to implant, simple to program, and extremely versatile. It provides physicians and patients with an exceptional array of lead configuration, programming, and patient-controlled options.
Benefits for Patients
* 8-contact primary cell IPG system
* Compact size with the highest battery capacity among small primary cell IPGs2
* Efficient circuitry and high-capacity battery